Patents by Inventor Travis JEANNOTTE

Travis JEANNOTTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PURIFICATION OF MESSENGER RNA
    Publication number: 20220170061
    Abstract: The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use.
    Type: Application
    Filed: October 11, 2021
    Publication date: June 2, 2022
    Inventors: Joseph Parella, Kimberly Gillis, Jonathan Abysalh, Travis Jeannotte, Erik Held, Frank DeRosa, Michael Heartlein, Rebecca Powell
  • Methods for purification of messenger RNA
    Patent number: 11174500
    Abstract: The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: November 16, 2021
    Assignee: Translate Bio, Inc.
    Inventors: Joseph Parella, Kimberly Gillis, Jonathan Abysalh, Travis Jeannotte, Erik Held, Frank DeRosa, Michael Heartlein, Rebecca Powell
  • METHODS FOR PURIFICATION OF MESSENGER RNA
    Publication number: 20200095571
    Abstract: The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use.
    Type: Application
    Filed: August 26, 2019
    Publication date: March 26, 2020
    Inventors: Joseph Parella, Kimberly Gillis, Jonathan Abysalh, Travis Jeannotte, Erik Held, Frank DeRosa, Michael Heartlein, Rebecca Powell
  • Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host
    Publication number: 20190321295
    Abstract: Encapsulated nucleic acid nanoparticles of uniformly small particle size are produced by intersecting one or more nucleic acid streams with one or more lipid streams. The encapsulated nucleic acid nanoparticles include a nucleic acid encapsulated within a lipid nanoparticle host. Uniformly small particle sizes are obtained by intersecting an aqueous nucleic acid stream and a stream of lipids in organic solvent at high linear velocities and with total organic solvent concentrations less than 33%.
    Type: Application
    Filed: May 30, 2019
    Publication date: October 24, 2019
    Inventors: Keith A. Bowman, Noah Gardner, Travis Jeannotte, Chandra Vargeese
  • Method of encapsulating a nucleic acid in a lipid nanoparticle host
    Patent number: 10342761
    Abstract: Encapsulated nucleic acid nanoparticles of uniformly small particle size are produced by intersecting one or more nucleic acid streams with one or more lipid streams. The encapsulated nucleic acid nanoparticles include a nucleic acid encapsulated within a lipid nanoparticle host. Uniformly small particle sizes are obtained by intersecting an aqueous nucleic acid stream and a stream of lipids in organic solvent at high linear velocities and with total organic solvent concentrations less than 33%.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: July 9, 2019
    Assignee: Novartis AG
    Inventors: Keith A. Bowman, Noah Gardner, Travis Jeannotte, Chandra Vargeese
  • METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST
    Publication number: 20170196809
    Abstract: Encapsulated nucleic acid nanoparticles of uniformly small particle size are produced by intersecting one or more nucleic acid streams with one or more lipid streams. The encapsulated nucleic acid nanoparticles include a nucleic acid encapsulated within a lipid nanoparticle host. Uniformly small particle sizes are obtained by intersecting an aqueous nucleic acid stream and a stream of lipids in organic solvent at high linear velocities and with total organic solvent concentrations less than 33%.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 13, 2017
    Inventors: Keith A. BOWMAN, Noah GARDNER, Travis JEANNOTTE, Chandra VARGEESE